Commentary: It's better to be alone than in bad company…at least for bioprosthesis
[摘要] Differential benefits and risks with the use of bioprostheses and mechanical aortic valves are an issue of debate, and any large registry data that address these issues are always novel and welcome. Rodriguez-Caulo and colleagues1 evaluated survival and major adverse cardiac events as primary outcomes in a large registry that included 50- to 65-year-old patients who underwent isolated aortic valve replacement (AVR) from 2000 to 2018 at 27 hospitals in Spain. Propensity matching (2:1) yielded 1822 patients with a mechanical prosthesis and 911 patients with a bioprosthesis.
[发布日期] [发布机构]
[效力级别] [学科分类] 心脏病和心血管学
[关键词] [时效性]